Journey Medical Corp cotiza a 5.68 USD y tiene una capitalización bursátil de $160M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of p…
| Periodo | 2026-05 | 2026-03 | 2025-11 | 2025-08 |
|---|---|---|---|---|
| Real | $-0.08 | $-0.04 | $-0.09 | $-0.16 |
| Estimado | $-0.09 | $-0.06 | $-0.04 | $-0.10 |
| Sorpresa | +11.1% | +33.3% | -125.0% | -60.0% |
| Métrica | DERM | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 66.2% | 57.0% | +9.1% |
| Operating Margin | -13.2% | -38.6% | +25.4% |
| Net Margin | -18.5% | -33.6% | +15.1% |
| FCF Margin | — | -13.9% | — |
| ROE | -35.9% | -40.4% | +4.5% |
| ROA | -12.1% | -32.0% | +19.9% |
| Current Ratio | 1.79 | 2.84 | -1.05 |
| Debt / Equity | 0.79 | 0.28 | +0.51 |